By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Puma Biotechnology 

10940 Wilshire Blvd, Suite 600

Los Angeles  Caliornia   90024  U.S.A.
Phone: 310-443-4150 Fax: 310-443-4158


Company News
Puma Biotechnology (PBYI) Announces Positive Initial Results From PB272 Phase II Trial In HER2 Mutated Non-Small Cell Lung Cancer 9/29/2014 11:40:22 AM
Puma Biotechnology (PBYI) Announces Late-Breaking Oral Presentation On Neratinib In NSCLC With HER2 Mutations At ESMO 2014 9/3/2014 8:58:09 AM
Puma Biotechnology (PBYI) Reports Second Quarter 2014 Financial Results 8/12/2014 8:39:42 AM
Puma Biotechnology (PBYI)'s Overnight Billionaire On One Of His Keys To Success 7/31/2014 7:02:13 AM
Puma Biotechnology (PBYI) Shares Soar On Breast Cancer Drug Results 7/23/2014 8:58:42 AM
Puma Biotechnology (PBYI) To Present At The Goldman, Sachs & Co. 35th Annual Global Healthcare Conference 6/6/2014 6:36:08 AM
Puma Biotechnology (PBYI) Announces Presentation Of Positive PB272 Phase II Data At The 2014 ASCO Annual Meeting 6/2/2014 9:17:15 AM
Puma Biotechnology (PBYI) To Present At Jefferies and Co. 2014 Global Healthcare Conference 5/29/2014 8:06:51 AM
Puma Biotechnology (PBYI) To Present At UBS Global Healthcare Conference 5/15/2014 9:51:20 AM
Puma Biotechnology (PBYI) Expands Cohort In Phase II Trial Of PB272 (Neratinib) In HER2 Mutation-Positive Solid Tumor Patients 5/14/2014 7:55:56 AM